A detailed history of Wincap Financial LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wincap Financial LLC holds 20,014 shares of BMY stock, worth $936,855. This represents 0.62% of its overall portfolio holdings.

Number of Shares
20,014
Previous 19,382 3.26%
Holding current value
$936,855
Previous $897 Million 0.61%
% of portfolio
0.62%
Previous 0.72%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$43.31 - $48.98 $27,371 - $30,955
632 Added 3.26%
20,014 $903 Million
Q2 2025

Aug 01, 2025

BUY
$44.12 - $59.6 $89,387 - $120,749
2,026 Added 11.67%
19,382 $897 Million
Q1 2025

May 07, 2025

BUY
$53.9 - $63.11 $31,908 - $37,361
592 Added 3.53%
17,356 $1.06 Billion
Q4 2024

May 07, 2025

BUY
$51.92 - $59.94 $870,386 - $1 Million
16,764 New
16,764 $948 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wincap Financial LLC Portfolio

Follow Wincap Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wincap Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wincap Financial LLC with notifications on news.